Long-term effectiveness of non-surgical interventions for chronic low back pain: a systematic review and meta-analysis.

IF 15 1区 医学 Q1 RHEUMATOLOGY
Hazel J Jenkins, Leticia Corrêa, Benjamin T Brown, Giovanni E Ferreira, Casper Nim, Sasha L Aspinall, Deborah Wareham, Junghyun Choi, Christopher G Maher, Mark J Hancock
{"title":"Long-term effectiveness of non-surgical interventions for chronic low back pain: a systematic review and meta-analysis.","authors":"Hazel J Jenkins, Leticia Corrêa, Benjamin T Brown, Giovanni E Ferreira, Casper Nim, Sasha L Aspinall, Deborah Wareham, Junghyun Choi, Christopher G Maher, Mark J Hancock","doi":"10.1016/S2665-9913(25)00064-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic low back pain is a long-term recurrent condition. Interventions with sustained benefits are needed to reduce the associated personal and societal burden. We aimed to assess the long-term effectiveness of non-surgical interventions for reducing pain intensity and disability in adults with chronic low back pain.</p><p><strong>Methods: </strong>We performed a systematic review and meta-analysis. MEDLINE, EMBASE, and CINAHL were searched from inception until May 22, 2024, for randomised controlled trials assessing non-surgical interventions in adults with chronic low back pain. Studies assessing pain intensity outcomes, disability outcomes, or both at long-term (1-2 years) and very long-term (≥2 years) follow-up were included. Comparators included placebo, adjuvant intervention, no intervention, or usual care. Study characteristics and outcome measures were extracted and risk of bias assessed. Random effects meta-analysis was performed for studies with similar populations, interventions, and outcome measures. We involved people with experience living with or treating chronic low back pain in the design and interpretation of this review. The review protocol was prospectively registered in PROSPERO (CRD42023408537).</p><p><strong>Findings: </strong>75 trials (15 395 participants) were included. Risk of bias was rated high for the majority of studies (51 [68%] of 75). In people with non-specific chronic low back pain at long-term follow-up, there was moderate certainty evidence that cognitive behavioural therapy and mindfulness probably result in reductions in pain intensity (mean difference -7·2 [95% CI -9·8 to -4·6]; I<sup>2</sup> =0·0 for cognitive behavioural therapy and -10·0 [-14·4 to -5·6]; I<sup>2</sup> =0·1 for mindfulness) and disability (-5·7 [-7·7 to -3·7]; I<sup>2</sup> =0·0 and -9·3 [-14·4 to -4·1]; I<sup>2</sup> =11·1). Goal setting (-8·3 [-12·8 to -3·9]; I<sup>2</sup> =4·8) and needling (-4·8 [-8·1 to -1·5]; I<sup>2</sup> =0·0) probably reduce disability at long-term follow-up. There was low certainty evidence that multidisciplinary care could reduce pain intensity (-10·1 [-16·6 to -3·7; I<sup>2</sup> =0·0) and exercise might reduce disability (-10·2 [-17·5 to -2·9]; I<sup>2</sup> =33·5) at very long-term follow-up. Heterogeneity was evident in several of the meta-analyses, and results should be interpreted with caution.</p><p><strong>Interpretation: </strong>Some interventions, including cognitive behavioural therapy, mindfulness, exercise, and multidisciplinary care could produce the long-term benefits required to reduce the global burden due to non-specific chronic low back pain; however, the effects are mostly small, and the strength of evidence is relatively uncertain. Greater attention is needed on developing and testing interventions with long-term effects for chronic low back pain.</p><p><strong>Funding: </strong>None.</p>","PeriodicalId":48540,"journal":{"name":"Lancet Rheumatology","volume":" ","pages":""},"PeriodicalIF":15.0000,"publicationDate":"2025-05-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/S2665-9913(25)00064-5","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Chronic low back pain is a long-term recurrent condition. Interventions with sustained benefits are needed to reduce the associated personal and societal burden. We aimed to assess the long-term effectiveness of non-surgical interventions for reducing pain intensity and disability in adults with chronic low back pain.

Methods: We performed a systematic review and meta-analysis. MEDLINE, EMBASE, and CINAHL were searched from inception until May 22, 2024, for randomised controlled trials assessing non-surgical interventions in adults with chronic low back pain. Studies assessing pain intensity outcomes, disability outcomes, or both at long-term (1-2 years) and very long-term (≥2 years) follow-up were included. Comparators included placebo, adjuvant intervention, no intervention, or usual care. Study characteristics and outcome measures were extracted and risk of bias assessed. Random effects meta-analysis was performed for studies with similar populations, interventions, and outcome measures. We involved people with experience living with or treating chronic low back pain in the design and interpretation of this review. The review protocol was prospectively registered in PROSPERO (CRD42023408537).

Findings: 75 trials (15 395 participants) were included. Risk of bias was rated high for the majority of studies (51 [68%] of 75). In people with non-specific chronic low back pain at long-term follow-up, there was moderate certainty evidence that cognitive behavioural therapy and mindfulness probably result in reductions in pain intensity (mean difference -7·2 [95% CI -9·8 to -4·6]; I2 =0·0 for cognitive behavioural therapy and -10·0 [-14·4 to -5·6]; I2 =0·1 for mindfulness) and disability (-5·7 [-7·7 to -3·7]; I2 =0·0 and -9·3 [-14·4 to -4·1]; I2 =11·1). Goal setting (-8·3 [-12·8 to -3·9]; I2 =4·8) and needling (-4·8 [-8·1 to -1·5]; I2 =0·0) probably reduce disability at long-term follow-up. There was low certainty evidence that multidisciplinary care could reduce pain intensity (-10·1 [-16·6 to -3·7; I2 =0·0) and exercise might reduce disability (-10·2 [-17·5 to -2·9]; I2 =33·5) at very long-term follow-up. Heterogeneity was evident in several of the meta-analyses, and results should be interpreted with caution.

Interpretation: Some interventions, including cognitive behavioural therapy, mindfulness, exercise, and multidisciplinary care could produce the long-term benefits required to reduce the global burden due to non-specific chronic low back pain; however, the effects are mostly small, and the strength of evidence is relatively uncertain. Greater attention is needed on developing and testing interventions with long-term effects for chronic low back pain.

Funding: None.

慢性腰痛非手术干预的长期有效性:一项系统回顾和荟萃分析。
背景:慢性腰痛是一种长期复发的疾病。需要有持续效益的干预措施,以减轻相关的个人和社会负担。我们的目的是评估非手术干预在减轻成人慢性腰痛疼痛强度和残疾方面的长期有效性。方法:我们进行了系统回顾和荟萃分析。MEDLINE, EMBASE和CINAHL从成立到2024年5月22日进行了检索,以评估非手术干预成人慢性腰痛的随机对照试验。研究评估疼痛强度结局、残疾结局,或在长期(1-2年)和非常长期(≥2年)随访中评估两者。比较者包括安慰剂、辅助干预、不干预或常规护理。提取研究特征和结果测量并评估偏倚风险。对具有相似人群、干预措施和结果测量的研究进行随机效应荟萃分析。我们在本综述的设计和解释中纳入了有慢性腰痛生活经历或治疗经验的人。该审查方案在PROSPERO (CRD42023408537)前瞻性注册。结果:纳入75项试验(15395名受试者)。大多数研究的偏倚风险被评为高(75项研究中有51项[68%])。在长期随访的非特异性慢性腰痛患者中,有中等确定性的证据表明,认知行为疗法和正念疗法可能导致疼痛强度的减轻(平均差值为- 7.2 [95% CI - 9.8至- 4.6];认知行为治疗I2 =0·0,-10·0[-14·4 ~ -5·6];正念组I2 =0·1)和残疾组(-5·7[-7·7至-3·7];I2 =0·0和-9·3[-14·4 ~ -4·1];I2 = 11·1)。目标设定(- 8.3[- 12.8至- 3.9];I2 =4·8)和针刺(-4·8[-8·1 ~ -1·5];I2 =0·0)可能在长期随访中减少残疾。有低确定性证据表明,多学科护理可以减轻疼痛强度(- 10.1[- 16.6至- 3.7;I2 =0·0),运动可减少残疾(-10·2[-17·5至-2·9];I2 =33·5)。异质性在一些荟萃分析中很明显,结果应谨慎解释。解释:一些干预措施,包括认知行为疗法、正念、锻炼和多学科护理,可以产生减少非特异性慢性腰痛造成的全球负担所需的长期效益;然而,这些影响大多很小,证据的力度也相对不确定。需要更多地关注开发和测试对慢性腰痛有长期影响的干预措施。资金:没有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Lancet Rheumatology
Lancet Rheumatology RHEUMATOLOGY-
CiteScore
34.70
自引率
3.10%
发文量
279
期刊介绍: The Lancet Rheumatology, an independent journal, is dedicated to publishing content relevant to rheumatology specialists worldwide. It focuses on studies that advance clinical practice, challenge existing norms, and advocate for changes in health policy. The journal covers clinical research, particularly clinical trials, expert reviews, and thought-provoking commentary on the diagnosis, classification, management, and prevention of rheumatic diseases, including arthritis, musculoskeletal disorders, connective tissue diseases, and immune system disorders. Additionally, it publishes high-quality translational studies supported by robust clinical data, prioritizing those that identify potential new therapeutic targets, advance precision medicine efforts, or directly contribute to future clinical trials. With its strong clinical orientation, The Lancet Rheumatology serves as an independent voice for the rheumatology community, advocating strongly for the enhancement of patients' lives affected by rheumatic diseases worldwide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信